Insider Shareholders with Direct Ownership of Neurocrine Biosciences Inc (NBIX)
This section provides a comprehensive overview of the insiders with direct ownership of Neurocrine Biosciences Inc (NBIX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NEUROCRINE BIOSCIENCES INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Kevin Charles Gorman
Chief Executive Officer |
481,198 | 555,302 | 514,596 $68.5 Million | 21 |
Feb 13, 2024
Reduced 0.55%
|
|
Haig P. Bozigian
Chief Development Officer |
0 | 6,803 | 157,651 $21 Million | 3 |
Feb 08, 2021
Reduced 1.02%
|
|
Kyle Gano
Chief Executive Officer |
103,266 | 144,923 | 135,166 $18 Million | 18 |
Feb 13, 2024
Reduced 0.99%
|
|
Gary A Lyons
Director |
72,100 | 102,000 | 119,047 $15.8 Million | 23 |
Aug 13, 2024
Reduced 8.86%
|
|
Dimitri E. Grigoriadis
Chief Research Officer |
5,000 | 13,570 | 82,273 $10.9 Million | 5 |
Oct 07, 2021
Reduced 5.73%
|
|
Malcolm Lloyd Smith
Chief Integration Officer |
49,946 | 85,361 | 42,337 $5.63 Million | 19 |
Feb 08, 2023
Reduced 1.63%
|
|
Eric Benevich
Chief Commercial Officer |
278,651 | 330,396 | 40,778 $5.43 Million | 40 |
Apr 15, 2024
Reduced 23.59%
|
|
Darin Lippoldt
Chief Legal Officer |
117,024 | 171,513 | 39,740 $5.29 Million | 45 |
Aug 01, 2024
Reduced 7.01%
|
|
William H Rastetter
Director |
60,000 | 47,259 | 37,491 $4.99 Million | 11 |
Aug 15, 2024
Reduced 27.54%
|
|
Richard F Pops
Director |
74,199 | 72,100 | 31,611 $4.21 Million | 14 |
May 17, 2024
Reduced 6.23%
|
|
Matt Abernethy
Chief Financial Officer |
45,000 | 94,645 | 31,528 $4.19 Million | 23 |
Aug 13, 2024
Reduced 30.9%
|
|
Eiry Roberts
Chief Medical Officer |
107,345 | 163,860 | 31,061 $4.13 Million | 26 |
Nov 08, 2024
Added 0.0%
|
|
Stephen A Sherwin
Director |
89,199 | 94,556 | 24,504 $3.26 Million | 11 |
Nov 04, 2024
Reduced 7.55%
|
|
Julie Cooke
Chief Human Resources Officer |
61,532 | 110,662 | 18,202 $2.42 Million | 35 |
Aug 01, 2024
Reduced 40.97%
|
|
Jude Onyia
Chief Scientific Officer |
4,426 | 16,383 | 15,449 $2.06 Million | 9 |
Nov 29, 2024
Reduced 13.11%
|
|
George J Morrow
Director |
44,199 | 40,000 | 4,199 $558,676 | 3 |
May 17, 2024
Added 50.0%
|
|
Ingrid Delaet
Chief Regulatory Officer |
23,180 | 32,776 | 2,507 $333,556 | 31 |
Aug 13, 2024
Reduced 62.06%
|
|
Johanna Mercier
Director |
2,100 | 0 | 2,100 $279,405 | 1 |
May 17, 2024
Added 50.0%
|
|
Leslie V Norwalk
Director |
10,100 | 9,106 | 994 $132,251 | 4 |
May 17, 2024
Reduced 52.67%
|
|
Shalini Sharp
Director |
2,100 | 1,106 | 994 $132,251 | 2 |
May 17, 2024
Reduced 52.67%
|
|
David W. Boyer
Chief Corp. Affairs Officer |
0 | 46,231 | 377 $50,159 | 17 |
Oct 03, 2024
Reduced 77.45%
|